Related Experiment Video
Updated: Oct 15, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
Presenting Characteristics, Comorbidities, and Outcomes Among Patients With COVID-19 Hospitalized in Pakistan:
Hashaam Akhtar1, Sundas Khalid2, Fazal Ur Rahman3
1Yusra Institute of Pharmaceutical Sciences, Islamabad, Pakistan.
Insights
Older adults with comorbidities like hypertension and diabetes face higher risks of severe COVID-19 and adverse outcomes. This study highlights key symptoms and risk factors for better patient management.
Area of Science:
- Medical Research
- Epidemiology
- Clinical Medicine
Background:
- COVID-19 rapidly became a global pandemic in December 2019.
- Pakistan's healthcare system faced challenges in documenting COVID-19 data.
- Pre-existing comorbidities in Pakistan's population can worsen COVID-19 outcomes.
Purpose of the Study:
- To examine clinical manifestations of COVID-19.
- To identify indicators for early detection and severity prognosis.
- To focus on high-risk patient groups.
Main Methods:
- A retrospective observational study of 1812 COVID-19 patients in Pakistan (February-August 2020).
- Data abstraction included demographics, symptoms, and clinical outcomes.
- Multivariate regression identified indicators for severity, ICU admission, ventilation, and mortality.
Main Results:
- Prevalent symptoms: fever (87.9%), cough (79.1%), shortness of breath (55.1%).
- 24.4% required ICU admission, 21.5% needed ventilators, and 25.9% died.
- Older adults with comorbidities (hypertension, diabetes, CKD, asthma) had significantly higher risks of severe outcomes.
Conclusions:
- Older adults with comorbidities are at increased risk for severe COVID-19.
- Hypertension, diabetes, asthma, COPD, and CKD are associated with adverse clinical outcomes.
- Understanding these factors is crucial for managing COVID-19 in vulnerable populations.
Background:
COVID-19 became a pandemic rapidly after its emergence in December 2019. It belongs to the coronavirus family of viruses, which have struck a few times before in history. Data based on previous research regarding etiology and epidemiology of other viruses from this family helped played a vital role in formulating prevention and precaution strategies during the initial stages of this pandemic. Data related to COVID-19 in Pakistan were not initially documented on a large scale. In addition, due to a weak health care system and low economic conditions, Pakistan's population, in general, already suffers from many comorbidities, which can severely affect the outcome of patients infected with COVID-19.
Objective:
COVID-19 infections are coupled with a manifestation of various notable outcomes that can be documented and characterized clinically. The aim of this study was to examine these clinical manifestations, which can serve as indicators for early detection as well as severity prognosis for COVID-19 infections, especially in high-risk groups.
Methods:
A retrospective observational study involving abstraction of demographic features, presenting symptoms, and adverse clinical outcomes for 1812 patients with COVID-19 was conducted. Patients were admitted to the four major hospitals in the Rawalpindi-Islamabad region of Pakistan, and the study was conducted from February to August 2020. Multivariate regression analysis was carried out to identify significant indicators of COVID-19 severity, intensive care unit (ICU) admission, ventilator aid, and mortality. The study not only relates COVID-19 infection with comorbidities, but also examines other related factors, such as age and gender.
Results:
This study identified fever (1592/1812, 87.9%), cough (1433/1812, 79.1%), and shortness of breath (998/1812, 55.1%) at the time of hospital admission as the most prevalent symptoms for patients with COVID-19. These symptoms were common but not conclusive of the outcome of infection. Out of 1812 patients, 24.4% (n=443) required ICU admission and 21.5% (n=390) required ventilator aid at some point of disease progression during their stay at the hospital; 25.9% (n=469) of the patients died. Further analysis revealed the relationship of the presented symptoms and comorbidities with the progression of disease severity in these patients. Older adult patients with comorbidities, such as hypertension, diabetes, chronic kidney disease, and asthma, were significantly affected in higher proportions, resulting in requirement of ICU admission and ventilator aid in some cases and, in many cases, even mortality.
Conclusions:
Older adult patients with comorbidities, such as hypertension, diabetes, asthma, chronic obstructive pulmonary disorder, and chronic kidney disease, are at increased risk of developing severe COVID-19 infections, with an increased likelihood of adverse clinical outcomes.
More Related Videos
08:05Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
09:36Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Related Concept Videos
Pneumonia III: Complications and Assessment
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care